Literature DB >> 7866845

A randomized study of manual therapy with steroid injections in low-back pain. Telephone interview follow-up of pain, disability, recovery and drug consumption.

S Blomberg1, K Svärdsudd, G Tibblin.   

Abstract

A total of 101 outpatients with acute or sub-acute low-back pain was randomly allocated to one of two treatment groups. One group was given standardised conventional and optimised activating treatment by primary health care teams. The other group received, according to a pragmatic approach, another treatment programme including manipulation, specific mobilisation, muscle stretching, autotraction and cortisone injections. The treatment effect was evaluated by standardised telephone interviews 3, 7, 14, 21 and 90 days after the start of treatment. The two groups were similar in most of the pretrial variables, including age, sex, occupation, education, previous low-back pain problems, previous treatment, sick-leave, findings at the physical examination, quality-of-life score, presence of common symptoms, disability rating and pain score. In the early phase as well as at the 90 days' follow-up, the group receiving manual therapy had significantly less pain, less disability, faster rate of recovery and lower drug consumption, indicating that this type of treatment is superior to conventional treatment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7866845     DOI: 10.1007/bf02226573

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  10 in total

1.  A controlled, multicentre trial of manual therapy in low-back pain. Initial status, sick-leave and pain score during follow-up.

Authors:  S Blomberg; K Svärdsudd; F Mildenberger
Journal:  Scand J Prim Health Care       Date:  1992-09       Impact factor: 2.581

2.  A controlled trial of manipulation in a selected group of patients with low back pain favouring one side.

Authors:  J W Fisk
Journal:  N Z Med J       Date:  1979-10-10

Review 3.  A critical look at the treatment for low back pain.

Authors:  A Nachemson
Journal:  Scand J Rehabil Med       Date:  1979

4.  A benefit of spinal manipulation as adjunctive therapy for acute low-back pain: a stratified controlled trial.

Authors:  N M Hadler; P Curtis; D B Gillings; S Stinnett
Journal:  Spine (Phila Pa 1976)       Date:  1987-09       Impact factor: 3.468

5.  Manual therapy with steroid injections--a new approach to treatment of low back pain. A controlled multicenter trial with an evaluation by orthopedic surgeons.

Authors:  S Blomberg; G Hallin; K Grann; E Berg; U Sennerby
Journal:  Spine (Phila Pa 1976)       Date:  1994-03-01       Impact factor: 3.468

6.  Manual therapy with steroid injections in low-back pain. Improvement of quality of life in a controlled trial with four months' follow-up.

Authors:  S Blomberg; K Svärdsudd; G Tibblin
Journal:  Scand J Prim Health Care       Date:  1993-06       Impact factor: 2.581

7.  Acute low back pain. Comparison of two conservative treatment approaches.

Authors:  J P Farrell; L T Twomey
Journal:  Med J Aust       Date:  1982-02-20       Impact factor: 7.738

8.  A prospective study of low back pain in a general population. I. Occurrence, recurrence and aetiology.

Authors:  F Biering-Sørensen
Journal:  Scand J Rehabil Med       Date:  1983

9.  Treatment of pelvic joint dysfunction in primary care--a controlled study.

Authors:  U Wreje; B Nordgren; H Aberg
Journal:  Scand J Prim Health Care       Date:  1992-12       Impact factor: 2.581

10.  Relative therapeutic efficacy of vertebral manipulation and conventional treatment in back pain management.

Authors:  V C Nwuga
Journal:  Am J Phys Med       Date:  1982-12
  10 in total
  1 in total

Review 1.  Association of Spinal Manipulative Therapy With Clinical Benefit and Harm for Acute Low Back Pain: Systematic Review and Meta-analysis.

Authors:  Neil M Paige; Isomi M Miake-Lye; Marika Suttorp Booth; Jessica M Beroes; Aram S Mardian; Paul Dougherty; Richard Branson; Baron Tang; Sally C Morton; Paul G Shekelle
Journal:  JAMA       Date:  2017-04-11       Impact factor: 56.272

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.